Sutter Valley Hospitals

Sutter Valley Hospitals was paid $105.25M by Medicaid between Jan 2018 and Dec 2024, across 385 billing codes. Its largest line is 0450, Emergency room services — 13% of everything it billed.

33Billing provider infoSUTTER VALLEY HOSPITALS
SACRAMENTO, CA 95816

33aNPI1811946734assigned 05/08/2006

33bProvider typeInfusion Therapy Clinic/Center

28Total paid$105.25M

24GClaims2,124,221

24DCodes billed385

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other Infusion Therapy Clinic/Center providers in California

Rank by total paid#1 of 11

Median peer was paid$20K

This provider vs. median5,286×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	339,696	$15.02M
2019	316,358	$14.19M
2020	250,430	$11.30M
2021	298,704	$14.57M
2022	314,808	$17.26M
2023	329,223	$18.07M
2024incomplete	275,002	$14.84M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
0450	Emergency room services	13%	160,208	138,983	$14.12M
99199	Unlisted special service, procedure or report	9.0%	84,825	71,242	$9.43M
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	3.9%	7,357	7,013	$4.13M
74177	Computed tomography, abdomen and pelvis; with contrast material	3.2%	9,482	9,121	$3.38M
70450	Computed tomography, head or brain; without contrast material	2.9%	13,136	12,653	$3.05M
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	2.3%	10,239	9,981	$2.37M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	2.2%	21,502	18,122	$2.31M
0202U	Oncology (prostate), multianalyte, gene expression profiling	1.9%	4,653	4,553	$2.05M
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	1.9%	9,719	9,414	$1.98M
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	1.8%	19,031	17,412	$1.86M
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	1.7%	20,985	19,058	$1.80M
99281	Emergency department visit for the evaluation and management, self-limited or minor	1.7%	13,301	11,631	$1.74M

373 more codes

80053	Comprehensive metabolic panel	1.6%	97,243	$1.70M
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	1.5%	41,672	$1.63M
J3490	Unclassified drugs	1.5%	99,337	$1.58M
0270		1.4%	43,935	$1.49M
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	1.4%	20,352	$1.43M
71046	Radiologic examination, chest; 2 views	1.3%	38,492	$1.42M
85025	Blood count; complete (CBC), automated, and automated differential WBC count	1.3%	122,794	$1.37M
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	1.3%	13,286	$1.34M
0762		1.2%	1,795	$1.29M
Z7502		1.0%	28,835	$1.07M
96375	Therapeutic injection; each additional sequential IV push	<1%	17,874	$1.03M
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	4,634	$1.00M
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	26,492	$1.00M
T1999	Miscellaneous therapeutic items and supplies, retail purchases, not otherwise classified; identify product in "remarks"	<1%	34,627	$982K
72125	Computed tomography, cervical spine; without contrast material	<1%	3,134	$969K
99499		<1%	13,031	$903K
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	4,862	$902K
Z4300		<1%	8,131	$839K
0160		<1%	2,463	$770K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	7,521	$711K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	8,050	$709K
99285	Emergency room visit (most serious)	<1%	3,694	$694K
99284	Emergency room visit (serious)	<1%	5,316	$683K
83880		<1%	16,810	$670K
82077		<1%	6,514	$628K
93971		<1%	3,694	$600K
71275	Computed tomographic angiography, chest, with contrast material	<1%	1,833	$594K
87486		<1%	8,455	$585K
84484		<1%	38,795	$584K
87581		<1%	8,455	$578K
41899	Unlisted procedure, dentoalveolar structures	<1%	1,045	$573K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	8,925	$572K
Z4304		<1%	7,212	$558K
96361	Intravenous infusion, hydration; each additional hour	<1%	11,046	$555K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	8,642	$544K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	1,382	$492K
0250		<1%	16,022	$480K
Z9725		<1%	11,046	$475K
76801		<1%	5,043	$468K
70486		<1%	1,741	$466K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	4,459	$463K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	5,066	$459K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	4,248	$456K
83690		<1%	39,401	$427K
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	1,715	$426K
87086	Culture, bacterial; quantitative colony count, urine	<1%	36,280	$417K
0510		<1%	8,019	$392K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	6,973	$385K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	16,698	$375K
71045	Radiologic examination, chest; single view	<1%	15,953	$373K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	658	$367K
76830	Ultrasound, transvaginal	<1%	3,360	$351K
99201		<1%	2,494	$350K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	3,813	$344K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	23,608	$337K
87040		<1%	16,580	$334K
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	4,190	$330K
96376		<1%	1,172	$324K
Z7500		<1%	9,109	$310K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	5,330	$299K
93970		<1%	1,104	$291K
95700		<1%	619	$289K
81001		<1%	53,903	$289K
80048	Basic metabolic panel (calcium, ionized)	<1%	17,430	$261K
95714		<1%	273	$256K
80143		<1%	2,326	$250K
59025	Fetal non-stress test	<1%	29,518	$243K
82803		<1%	8,892	$242K
Z4301		<1%	7,531	$237K
J7030	Infusion, normal saline solution , 1000 cc	<1%	19,941	$235K
Z4308		<1%	7,309	$222K
80179		<1%	2,093	$218K
Z5946		<1%	87	$216K
83605		<1%	13,782	$216K
81025		<1%	24,971	$211K
T1024	Evaluation and treatment by an integrated, specialty team contracted to provide coordinated care to multiple or severely handicapped children, per encounter	<1%	3,154	$209K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	3,693	$208K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	1,533	$195K
73630		<1%	4,784	$192K
87507		<1%	269	$182K
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	4,486	$182K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	5,407	$172K
73610		<1%	3,961	$172K
Z4307		<1%	6,492	$171K
73130		<1%	3,769	$169K
0760		<1%	5,733	$169K
84702		<1%	15,097	$168K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	17,604	$164K
72100		<1%	3,312	$159K
G9002	Coordinated care fee, maintenance rate	<1%	1,141	$158K
84145		<1%	5,303	$155K
73030		<1%	3,565	$153K
84443	Thyroid stimulating hormone (TSH)	<1%	6,184	$152K
73562		<1%	3,788	$151K
76770		<1%	1,194	$146K
86923		<1%	1,500	$139K
83735		<1%	14,151	$137K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	342	$137K
90715		<1%	2,272	$134K
96367		<1%	2,264	$132K
S0302	Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service)	<1%	1,478	$129K
74018		<1%	4,064	$123K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	13,699	$121K
73502		<1%	1,688	$120K
J7120	Ringers lactate infusion, up to 1000 cc	<1%	11,090	$119K
J2785	Injection, regadenoson, 0.1 mg	<1%	383	$113K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	8,943	$110K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	9,775	$104K
A9502	Technetium tc-99m tetrofosmin, diagnostic, per study dose	<1%	409	$102K
85730		<1%	11,060	$100K
X4500		<1%	1,058	$100K
73110		<1%	2,281	$100K
81003		<1%	26,713	$98K
96112		<1%	603	$97K
99282	Emergency department visit for the evaluation and management, low to moderate severity	<1%	903	$96K
Z4311		<1%	7,792	$94K
80076		<1%	7,522	$94K
86140		<1%	11,073	$92K
Z7610		<1%	9,645	$92K
0710		<1%	587	$89K
85379		<1%	5,104	$87K
Z4312		<1%	7,058	$85K
85610		<1%	14,897	$84K
T1001	Nursing assessment / evaluation	<1%	1,083	$82K
95810	Polysomnography; sleep staging with 4 or more additional parameters	<1%	172	$80K
0360		<1%	347	$80K
87186		<1%	8,891	$79K
87077		<1%	9,323	$76K
J2270	Injection, morphine sulfate, up to 10 mg	<1%	6,413	$76K
73080		<1%	1,684	$75K
Z5910		<1%	1,587	$74K
99368		<1%	2,339	$70K
70498		<1%	210	$70K
76870		<1%	847	$67K
72131		<1%	250	$66K
86850		<1%	5,886	$65K
73590		<1%	1,862	$65K
94644		<1%	2,024	$65K
X4301		<1%	680	$64K
82330		<1%	3,053	$62K
87430		<1%	4,005	$60K
J2704	Injection, propofol, 10 mg	<1%	4,363	$59K
95811		<1%	99	$58K
X4540		<1%	1,736	$57K
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	5,188	$57K
87081		<1%	4,537	$56K
86901		<1%	9,411	$54K
J1745	Injection, infliximab, excludes biosimilar, 10 mg	<1%	33	$54K
72040		<1%	1,231	$53K
70496		<1%	165	$52K
95816		<1%	458	$49K
93017		<1%	534	$48K
72070		<1%	1,026	$47K
87400		<1%	4,969	$47K
92557		<1%	249	$47K
G0378	Hospital observation service, per hour	<1%	395	$44K
73090		<1%	1,264	$44K
J1815	Injection, insulin, per 5 units	<1%	4,011	$43K
82947		<1%	7,291	$42K
95819		<1%	416	$41K
99401		<1%	1,517	$39K
74019		<1%	880	$39K
92567		<1%	568	$39K
Z4310		<1%	3,126	$38K
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	3,712	$38K
86900		<1%	8,478	$37K
99070		<1%	1,071	$35K
73140		<1%	1,154	$34K
Z4302		<1%	2,634	$34K
70491		<1%	95	$34K
99366		<1%	1,143	$34K
Z5928		<1%	673	$32K
P9016	Red blood cells, leukocytes reduced, each unit	<1%	109	$31K
82552		<1%	1,593	$31K
96415		<1%	759	$31K
82550		<1%	3,316	$30K
10060		<1%	951	$30K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	3,722	$30K
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	3,237	$30K
76816	Ultrasound, pregnant uterus, real time with image documentation, follow-up	<1%	441	$29K
J2060	Injection, lorazepam, 2 mg	<1%	3,370	$28K
83036	Hemoglobin; glycosylated (A1C)	<1%	1,792	$28K
84703		<1%	4,994	$28K
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	2,660	$27K
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	26	$27K
80061	Lipid panel	<1%	1,866	$27K
V5264	Ear mold/insert, not disposable, any type	<1%	517	$27K
Z4306		<1%	367	$26K
0761		<1%	558	$26K
36415	Collection of venous blood by venipuncture	<1%	19,137	$26K
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	1,528	$26K
97803		<1%	612	$26K
J7050	Infusion, normal saline solution, 250 cc	<1%	4,403	$24K
J1170	Injection, hydromorphone, up to 4 mg	<1%	1,681	$24K
95708		<1%	47	$23K
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	174	$23K
J3480	Injection, potassium chloride, per 2 meq	<1%	474	$22K
85027		<1%	2,638	$22K
S0164	Injection, pantoprazole sodium, 40 mg	<1%	1,154	$22K
J0561	Injection, penicillin g benzathine, 100,000 units	<1%	69	$22K
73560		<1%	732	$22K
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	2,645	$22K
J3475	Injection, magnesium sulfate, per 500 mg	<1%	1,866	$21K
71020		<1%	490	$20K
87634		<1%	253	$19K
Z4309		<1%	775	$19K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	794	$19K
87210		<1%	2,375	$18K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	2,652	$18K
87070		<1%	1,358	$17K
Z7506		<1%	297	$17K
G0463	Hospital outpatient clinic visit for assessment and management of a patient	<1%	1,080	$17K
93976		<1%	53	$17K
87420		<1%	1,298	$17K
84132		<1%	3,277	$16K
J1650	Injection, enoxaparin sodium, 10 mg	<1%	1,008	$16K
71250		<1%	59	$16K
0272		<1%	40	$16K
Q0162	Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	1,350	$15K
36430		<1%	27	$15K
99244	Office or other outpatient consultation, moderate to high complexity	<1%	268	$15K
85652		<1%	3,817	$15K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	2,478	$15K
80164		<1%	682	$14K
93325		<1%	70	$14K
96111		<1%	130	$14K
84439		<1%	1,165	$13K
J1644	Injection, heparin sodium, per 1000 units	<1%	940	$13K
A9585	Injection, gadobutrol, 0.1 ml	<1%	122	$13K
99080		<1%	126	$13K
97597		<1%	217	$13K
96417		<1%	187	$12K
0324		<1%	255	$12K
J0690	Injection, cefazolin sodium, 500 mg	<1%	1,058	$12K
84295		<1%	2,580	$12K
87205		<1%	1,769	$12K
J1756	Injection, iron sucrose, 1 mg	<1%	538	$11K
97750		<1%	138	$11K
96113		<1%	156	$11K
Z5406		<1%	332	$11K
90732		<1%	74	$11K
87147		<1%	1,588	$11K
42820	Tonsillectomy and adenoidectomy; younger than age 12	<1%	104	$11K
82140		<1%	621	$10K
S0028	Injection, famotidine, 20 mg	<1%	660	$10K
71100		<1%	197	$9K
86592		<1%	2,056	$9K
0301		<1%	193	$9K
92526		<1%	107	$9K
95953		<1%	12	$8K
J0360	Injection, hydralazine hcl, up to 20 mg	<1%	603	$8K
J7620	Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme	<1%	2,879	$8K
J0780	Injection, prochlorperazine, up to 10 mg	<1%	395	$8K
84550		<1%	1,541	$8K
J7611	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg	<1%	3,476	$7K
82731		<1%	652	$7K
90686		<1%	205	$7K
93320		<1%	56	$7K
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	2,705	$7K
73552		<1%	175	$7K
12001		<1%	144	$7K
83615		<1%	941	$7K
00000		<1%	215	$6K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	215	$6K
29125		<1%	349	$6K
S0077	Injection, clindamycin phosphate, 300 mg	<1%	265	$6K
J1940	Injection, furosemide, up to 20 mg	<1%	478	$6K
87088		<1%	807	$6K
J2560	Injection, phenobarbital sodium, up to 120 mg	<1%	40	$5K
J7510	Prednisolone oral, per 5 mg	<1%	1,161	$5K
12011		<1%	118	$5K
J7644	Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram	<1%	1,308	$5K
0121		<1%	12	$5K
82565		<1%	740	$5K
J8540	Dexamethasone, oral, 0.25 mg	<1%	1,825	$5K
J1630	Injection, haloperidol, up to 5 mg	<1%	507	$5K
82570		<1%	1,154	$5K
96156		<1%	201	$5K
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	31	$5K
0516		<1%	77	$5K
84450		<1%	740	$4K
86308		<1%	544	$4K
84460		<1%	724	$4K
73060		<1%	139	$4K
94729		<1%	217	$4K
J2550	Injection, promethazine hcl, up to 50 mg	<1%	443	$4K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	137	$4K
94726		<1%	237	$4K
Q4051	Splint supplies, miscellaneous (includes thermoplastics, strapping, fasteners, padding and other supplies)	<1%	26	$4K
96402		<1%	145	$4K
84100		<1%	833	$4K
J3370	Injection, vancomycin hcl, 500 mg	<1%	241	$4K
J0137	Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg	<1%	163	$4K
70360		<1%	151	$4K
82728		<1%	262	$4K
97802		<1%	107	$4K
96523		<1%	56	$4K
84112		<1%	857	$4K
98967		<1%	40	$4K
71010		<1%	127	$3K
81015		<1%	688	$3K
J2919	Injection, methylprednisolone sodium succinate, 5 mg	<1%	156	$3K
84156		<1%	1,121	$3K
87045		<1%	185	$3K
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	<1%	617	$3K
94645		<1%	129	$3K
0391		<1%	34	$3K
J1953	Injection, levetiracetam, 10 mg	<1%	144	$3K
J1453	Injection, fosaprepitant, 1 mg	<1%	79	$3K
93303	Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study	<1%	14	$3K
50590		<1%	13	$3K
99403		<1%	46	$3K
82247		<1%	856	$3K
87427		<1%	167	$2K
87015		<1%	198	$2K
82270		<1%	461	$2K
Z6406		<1%	88	$2K
87046		<1%	229	$2K
69436	Tympanostomy (requiring insertion of ventilating tube), general anesthesia	<1%	12	$1K
73100		<1%	42	$1K
93750		<1%	13	$1K
82248		<1%	228	$1K
0309		<1%	84	$1K
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	206	$1K
12002		<1%	26	$1K
J2003	Injection, lidocaine hydrochloride, 1 mg	<1%	61	$1K
97162		<1%	13	$1K
0320		<1%	18	$1K
J2300	Injection, nalbuphine hydrochloride, per 10 mg	<1%	76	$1K
93798		<1%	51	$977.94
97161		<1%	16	$939.53
J3360	Injection, diazepam, up to 5 mg	<1%	29	$926.58
82010		<1%	66	$886.04
87075		<1%	67	$858.12
80074		<1%	13	$821.58
94010		<1%	63	$770.67
72170		<1%	26	$684.65
83540		<1%	110	$676.81
82805		<1%	15	$620.26
90384		<1%	13	$606.73
S0020	Injection, bupivicaine hydrochloride, 30 ml	<1%	41	$515.10
73000		<1%	12	$513.90
Z6204		<1%	26	$494.60
83550		<1%	78	$466.72
82553		<1%	18	$433.75
J3411	Injection, thiamine hcl, 100 mg	<1%	50	$415.66
G8978	Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals	<1%	151	$390.75
Z7512		<1%	14	$365.82
94060		<1%	12	$364.51
J1171	Injection, hydromorphone, 0.1 mg	<1%	16	$353.04
J2470	Injection, pantoprazole sodium, 40 mg	<1%	46	$344.31
96151		<1%	17	$325.95
88300		<1%	54	$322.39
J7613	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	<1%	403	$217.98
J3105	Injection, terbutaline sulfate, up to 1 mg	<1%	17	$216.29
29105		<1%	13	$184.46
Z6304		<1%	13	$180.92
J0330	Injection, succinylcholine chloride, up to 20 mg	<1%	12	$168.31
J1956	Injection, levofloxacin, 250 mg	<1%	14	$148.90
0306		<1%	58	$142.63
J0280	Injection, aminophyllin, up to 250 mg	<1%	18	$136.40
J0456	Injection, azithromycin, 500 mg	<1%	12	$133.84
99404		<1%	24	$107.94
36600		<1%	14	$84.29
G8979	Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	150	$61.13
80197		<1%	23	$9.77
0730		0%	12	$0.00
0250R		0%	70	$0.00
0305		0%	85	$0.00
0307		0%	12	$0.00
G8980	Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting	0%	27	$0.00
0258		0%	12	$0.00
J2543	Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)	0%	17	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialNOAKES, TIMOTHY (CHIEF FINANCIAL OFFICER)